Cargando…
Sustained nicorandil administration reduces the infarct size in ST-segment elevation myocardial infarction patients with primary percutaneous coronary intervention
OBJECTIVE: Currently, there is still no effective strategy to diminish the infarct size (IS) in patients with ST-segment elevation myocardial infarction (STEMI). According to a previous animal study, nicorandil treatment is a promising pharmaceutical treatment to limit the infarct area. In this stud...
Autores principales: | Wang, Shanjie, Duan, Yu, Feng, Xinyu, Liu, Liang, Shi, Zhaofeng, Wang, Bo, Xia, Chenhai, Man, Wanrong, Wang, Haichang, Zhao, Zhijing, Sun, Dongdong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kare Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457402/ https://www.ncbi.nlm.nih.gov/pubmed/30821716 http://dx.doi.org/10.14744/AnatolJCardiol.2018.57383 |
Ejemplares similares
-
Effects of Nicorandil Administration on Infarct Size in Patients With ST‐Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: The CHANGE Trial
por: Qian, Geng, et al.
Publicado: (2022) -
Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment Elevation Myocardial Infarction treated with percutaneous coronary intervention
por: Campo, Gianluca, et al.
Publicado: (2017) -
Intracoronary Nicorandil and the Prevention of the No-Reflow Phenomenon During Primary Percutaneous Coronary Intervention in Patients with Acute ST-Segment Elevation Myocardial Infarction
por: Qi, Qi, et al.
Publicado: (2018) -
The effects of nicorandil on microvascular function in patients with ST segment elevation myocardial infarction undergoing primary PCI
por: Kostic, Jelena, et al.
Publicado: (2015) -
Effects of nicorandil on myocardial infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: study design and protocol for the randomized controlled trial
por: JIANG, Xiao-Si, et al.
Publicado: (2020)